Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3320)
All Articles published online
|
Aug 21, 2007 (publication date) through Jan 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wistuba W, Gnewuch C, Liebisch G, Schmitz G, Langmann T. Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR. World J Gastroenterol 2007; 13(31): 4230-4235 [PMID: 17696253 DOI: 10.3748/wjg.v13.i31.4230] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i31/4230.htm |
| Number | Citing Articles |
| 1 |
Daniel Jahn, Monika Rau, Heike M. Hermanns, Andreas Geier. Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease. Cytokine & Growth Factor Reviews 2015; 26(6): 625 doi: 10.1016/j.cytogfr.2015.07.016
|
| 2 |
Justine H. Zhang, Jonathan D. Nolan, Sarah L. Kennie, Ian M. Johnston, Tracy Dew, Peter H. Dixon, Catherine Williamson, Julian R. F. Walters. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 304(10): G940 doi: 10.1152/ajpgi.00398.2012
|
| 3 |
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Bile acid receptors and gastrointestinal functions. Liver Research 2019; 3(1): 31 doi: 10.1016/j.livres.2019.01.001
|
| 4 |
E. Ekholm, R. Nilsson, L. Groop, C. Pramfalk. Alterations in bile acid synthesis in carriers of hepatocyte nuclear factor 1α mutations. Journal of Internal Medicine 2013; 274(3): 263 doi: 10.1111/joim.12082
|
| 5 |
Liping Yang, Mingyu Liu, Mengjuan Zhao, Shaoyang Zhi, Wenlei Zhang, Leya Qu, Jinrui Xiong, Xiao Yan, Chaobin Qin, Guoxing Nie, Shengpeng Wang, Jiting Wang. Dietary Bile Acid Supplementation Could Regulate the Glucose, Lipid Metabolism, and Microbiota of Common Carp (Cyprinus carpio L.) Fed with a High-Lipid Diet. Aquaculture Nutrition 2023; 2023: 1 doi: 10.1155/2023/9953927
|
| 6 |
Wei Sheng, Guang Ji, Li Zhang. The Effect of Lithocholic Acid on the Gut-Liver Axis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.910493
|
| 7 |
Moumita Dutta, Joe Jongpyo Lim, Julia Yue Cui. Pregnane X Receptor and the Gut-Liver Axis: A Recent Update. Drug Metabolism and Disposition 2022; 50(4): 478 doi: 10.1124/dmd.121.000415
|
| 8 |
Makoto Shimizu, Ryuichiro Sato. Endocrine Fibroblast Growth Factors in Relation to Stress Signaling. Cells 2022; 11(3): 505 doi: 10.3390/cells11030505
|
| 9 |
Jingwei Cai, Bipin Rimal, Changtao Jiang, John Y.L. Chiang, Andrew D. Patterson. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacology & Therapeutics 2022; 237: 108238 doi: 10.1016/j.pharmthera.2022.108238
|
| 10 |
Nicolas Creusot, Matthieu Gassiot, Elina Alaterre, Barbara Chiavarina, Marina Grimaldi, Abdelhay Boulahtouf, Lucia Toporova, Sabine Gerbal-Chaloin, Martine Daujat-Chavanieu, Alice Matheux, Roger Rahmani, Céline Gongora, Alexandre Evrard, Philippe Pourquier, Patrick Balaguer. The Anti-Cancer Drug Dabrafenib Is a Potent Activator of the Human Pregnane X Receptor. Cells 2020; 9(7): 1641 doi: 10.3390/cells9071641
|
| 11 |
Tiangang Li, John Y.L. Chiang, Qiang Ma. Bile Acid Signaling in Metabolic Disease and Drug Therapy. Pharmacological Reviews 2014; 66(4): 948 doi: 10.1124/pr.113.008201
|
| 12 |
Yuanyuan Zhang, Carl LaCerte, Sanjay Kansra, Jonathan P. Jackson, Kenneth R. Brouwer, Jeffrey E. Edwards. Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal in vitro cell models. Pharmacology Research & Perspectives 2017; 5(6) doi: 10.1002/prp2.368
|
| 13 |
Masaaki Miyata, Yuki Takamatsu, Hideaki Kuribayashi, Yasushi Yamazoe. Administration of Ampicillin Elevates Hepatic Primary Bile Acid Synthesis through Suppression of Ileal Fibroblast Growth Factor 15 Expression. The Journal of Pharmacology and Experimental Therapeutics 2009; 331(3): 1079 doi: 10.1124/jpet.109.160093
|
| 14 |
Tiangang Li, John Y. L. Chiang. Nuclear receptors in bile acid metabolism. Drug Metabolism Reviews 2013; 45(1): 145 doi: 10.3109/03602532.2012.740048
|
| 15 |
Matthew C. Cave, Heather B. Clair, Josiah E. Hardesty, K. Cameron Falkner, Wenke Feng, Barbara J. Clark, Jennifer Sidey, Hongxue Shi, Bashar A. Aqel, Craig J. McClain, Russell A. Prough. Nuclear receptors and nonalcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2016; 1859(9): 1083 doi: 10.1016/j.bbagrm.2016.03.002
|
| 16 |
Joseph L Dempsey, Dongfang Wang, Gunseli Siginir, Qiang Fei, Daniel Raftery, Haiwei Gu, Julia Yue Cui. Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis. Toxicological Sciences 2019; 168(1): 40 doi: 10.1093/toxsci/kfy271
|
| 17 |
Emmanuel Somm, François R Jornayvaz. Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives. Endocrine Reviews 2018; 39(6): 960 doi: 10.1210/er.2018-00134
|
| 18 |
Olga Renner, Simone Harsch, Silke Matysik, Dieter Lütjohann, Gerd Schmitz, Eduard F Stange. Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals. United European Gastroenterology Journal 2014; 2(3): 216 doi: 10.1177/2050640614527938
|
| 19 |
Masaaki Miyata, Tatsuya Hata, Hiroki Yamakawa, Tatehiro Kagawa, Kouichi Yoshinari, Yasushi Yamazoe. Involvement of multiple elements in FXR-mediated transcriptional activation of FGF19. The Journal of Steroid Biochemistry and Molecular Biology 2012; 132(1-2): 41 doi: 10.1016/j.jsbmb.2012.04.008
|
| 20 |
Frank G. Schaap, Michael Trauner, Peter L. M. Jansen. Bile acid receptors as targets for drug development. Nature Reviews Gastroenterology & Hepatology 2014; 11(1): 55 doi: 10.1038/nrgastro.2013.151
|
| 21 |
Chiara Degirolamo, Carlo Sabbà, Antonio Moschetta. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23. Nature Reviews Drug Discovery 2016; 15(1): 51 doi: 10.1038/nrd.2015.9
|
| 22 |
Amanda M. Styer, Stephen L. Roesch, George Argyropoulos, Antonio Moschetta. Modulation of Fibroblast Growth Factor 19 Expression by Bile Acids, Meal Replacement and Energy Drinks, Milk, and Coffee. PLoS ONE 2014; 9(1): e85558 doi: 10.1371/journal.pone.0085558
|
| 23 |
Joshua S. Fleishman, Sunil Kumar. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01811-6
|
| 24 |
Tadeja Režen, Damjana Rozman, Tünde Kovács, Patrik Kovács, Adrienn Sipos, Péter Bai, Edit Mikó. The role of bile acids in carcinogenesis. Cellular and Molecular Life Sciences 2022; 79(5) doi: 10.1007/s00018-022-04278-2
|
| 25 |
Liwei Lang, Austin Y. Shull, Yong Teng. Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression. Current Cancer Drug Targets 2018; 19(1): 17 doi: 10.2174/1568009618666180319091731
|
| 26 |
|
| 27 |
Masaaki Miyata, Tatsuya Hata, Yasushi Yamazoe, Kouichi Yoshinari. SREBP-2 negatively regulates FXR-dependent transcription of FGF19 in human intestinal cells. Biochemical and Biophysical Research Communications 2014; 443(2): 477 doi: 10.1016/j.bbrc.2013.11.126
|
| 28 |
Jing Zhang, Yueqiong Ni, Lingling Qian, Qichen Fang, Tingting Zheng, Mingliang Zhang, Qiongmei Gao, Ying Zhang, Jiacheng Ni, Xuhong Hou, Yuqian Bao, Petia Kovatcheva‐Datchary, Aimin Xu, Huating Li, Gianni Panagiotou, Weiping Jia. Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes. Advanced Science 2021; 8(16) doi: 10.1002/advs.202100536
|
| 29 |
Leigang Jin, Ranyao Yang, Leiluo Geng, Aimin Xu. Fibroblast Growth Factor–Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications. Annual Review of Pharmacology and Toxicology 2023; 63(1): 359 doi: 10.1146/annurev-pharmtox-032322-093904
|
| 30 |
Greg Guthrie, Caitlin Vonderohe, Douglas Burrin. Fibroblast growth factor 15/19 expression, regulation, and function: An overview. Molecular and Cellular Endocrinology 2022; 548: 111617 doi: 10.1016/j.mce.2022.111617
|
| 31 |
Marica Cariello, Marilidia Piglionica, Raffaella Maria Gadaleta, Antonio Moschetta. Bile Acids and Their Receptors. Handbook of Experimental Pharmacology 2019; 256: 73 doi: 10.1007/164_2019_235
|
| 32 |
Gabriella V. Hernandez, Victoria A. Smith, Megan Melnyk, Matthew A. Burd, Kimberly A. Sprayberry, Mark S. Edwards, Daniel G. Peterson, Darin C. Bennet, Rob K. Fanter, Daniel A. Columbus, Juan P. Steibel, Hunter Glanz, Chad Immoos, Margaret S. Rice, Tasha M. Santiago-Rodriguez, Jason Blank, Jennifer J. VanderKelen, Christopher L. Kitts, Brian D. Piccolo, Michael R. La Frano, Douglas G. Burrin, Magdalena Maj, Rodrigo Manjarin. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(3): G582 doi: 10.1152/ajpgi.00344.2019
|
| 33 |
Hongwei Wang, Madhukumar Venkatesh, Hao Li, Regina Goetz, Subhajit Mukherjee, Arunima Biswas, Liang Zhu, Andreas Kaubisch, Lei Wang, James Pullman, Kathleen Whitney, Makoto Kuro-o, Andres I. Roig, Jerry W. Shay, Moosa Mohammadi, Sridhar Mani. Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. Journal of Clinical Investigation 2011; 121(8): 3220 doi: 10.1172/JCI41514
|
| 34 |
Tiangang Li, Udayan Apte. Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer. Advances in Pharmacology 2015; 74: 263 doi: 10.1016/bs.apha.2015.04.003
|
| 35 |
Martin Haluzík, Helena Kratochvílová, Denisa Haluzíková, Miloš Mráz. Gut as an emerging organ for the treatment of diabetes: focus on mechanism of action of bariatric and endoscopic interventions. Journal of Endocrinology 2018; 237(1): R1 doi: 10.1530/JOE-17-0438
|
| 36 |
Stefano Fiorucci, Eleonora Distrutti, Adriana Carino, Angela Zampella, Michele Biagioli. Bile acids and their receptors in metabolic disorders. Progress in Lipid Research 2021; 82: 101094 doi: 10.1016/j.plipres.2021.101094
|
| 37 |
Rama Pai, Dorothy French, Ning Ma, Kathy Hotzel, Emile Plise, Laurent Salphati, Kenneth D. R. Setchell, Joseph Ware, Veronique Lauriault, Leah Schutt, Dylan Hartley, Donna Dambach. Antibody-Mediated Inhibition of Fibroblast Growth Factor 19 Results in Increased Bile Acids Synthesis and Ileal Malabsorption of Bile Acids in Cynomolgus Monkeys. Toxicological Sciences 2012; 126(2): 446 doi: 10.1093/toxsci/kfs011
|
| 38 |
Raffaella Maria Gadaleta, Antonio Moschetta. Metabolic Messengers: fibroblast growth factor 15/19. Nature Metabolism 2019; 1(6): 588 doi: 10.1038/s42255-019-0074-3
|
| 39 |
Gregory Guthrie, Barbara Stoll, Shaji Chacko, Charlotte Lauridsen, Jogchum Plat, Douglas Burrin. Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(1): G41 doi: 10.1152/ajpgi.00193.2019
|